Red Book provides the latest pricing and product information on prescription and over-the-counter drug products within the industry, enabling healthcare professionals to quickly answer drug-related questions with information for 200,000+ prescription and over-the-counter drugs, nutraceuticals, and bulk chemicals.
The Red Book serves as a resource for drug utilization reviews, market analysis and research, prescription pricing, and order entry. It establishes and validates reimbursement, forecasting, drug-pricing research, generic substitution, therapeutic interchange, competitive analysis, purchasing, forumulary development and management, as well as claims adjudication, processing and validation.
FlutiCare is Innovus' nationally branded OTC fluticasone propionate nasal spray, USP 50 mcg per spray, which is indicated to treat individuals with allergic rhinitis.
UriVarx targets the bladder and surrounding tissues to promote normal urination and strong bladder tone, and is clinically proven in an 8-week double blind placebo controlled clinical trial in 150 patients to support bladder tone and function.
Innovus Pharma is engaged in the commercialisation, licensing, and development of safe and effective non-prescription medicine and consumer care products to improve men's and women's health and vitality, and respiratory diseases.
Inimmune signs research collaboration with Boston Children's Hospital
ResVita Bio receives USD250,000 phase one Small Business Innovation Research grant from NIAID
Phase II Data of Oral Dexpramipexole Published in Eosinophilic Asthma
AllerVie Health Rebrands Southern Allergy & Asthma
Applied BioCode Inks Distribution Agreement with Medline Industries
Vedanta Biosciences Receives Fast Track Designation for VE303
KalVista Pharmaceuticals Presents Data at 13th C1-inhibitor Deficiency & Angioedema Workshop
French Ophthalmology Specialist Horus Pharma Group Launches a Nordic Subsidiary